NYSE •
Healthcare •
Biotechnology •
Quote as of 06/23/2026 15:37
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization599.03 mln
Float47.85 mln
Earnings Date08/06/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-3.19
Reliable
1-Year Forecast
8.50
Fairly priced
Relative Strength
93
/ 100
Top performer
Debt / Equity
0.93
Moderate leverage
ROE
-54.91
Deeply negative
Business Description
Founded in 2008 and based in Boston, Ginkgo Bioworks helps companies across industries design and build living cells for practical use, from developing new drugs and agricultural solutions to improving food ingredients and industrial processes. Its platform combines automation, artificial intelligence, and genomic tools to make cell engineering faster and more accessible for research and commercial applications. The company also operates a biosecurity division that monitors environmental and biological threats through sensor networks and data analytics.
